Form 4: Heron Therapeutics CFO Converts Restricted Stock Units to Common Shares

Heron Therapeutics' EVP and Chief Financial Officer, Ira Duarte, converted 3,874 restricted stock units into common shares, increasing direct beneficial ownership of common stock.

Summary

• Ira Duarte, the Executive Vice President and Chief Financial Officer of Heron Therapeutics, Inc. (HRTX), converted 3,874 restricted stock units (RSUs) into common stock.
• This transaction occurred on July 19, 2025.
• Following this conversion, Mr. Duarte directly beneficially owns 152,523 shares of common stock.
• Mr. Duarte also directly beneficially owns 38,743 restricted stock units.
• Each restricted stock unit represents a contingent right to receive one share of common stock.
• The restricted stock units vest in 16 equal quarterly installments, with the vesting period commencing one quarter after the grant date of January 19, 2024.

Sentiment

Score: 5

Explanation: The filing is a routine insider transaction (Form 4) reporting the conversion of restricted stock units to common shares, which is a standard part of executive compensation and does not inherently indicate positive or negative sentiment about the company's performance or outlook.

Positives

• The conversion of restricted stock units into common stock indicates the vesting of executive compensation, which is a routine and expected part of an executive's long-term incentive plan.

Future Outlook

The filing indicates the continued vesting schedule for the remaining 38,743 restricted stock units, which will vest in 16 equal quarterly installments beginning one quarter after January 19, 2024.

Industry Context

This Form 4 filing is a standard disclosure of an insider transaction, specifically the conversion of restricted stock units (RSUs) into common stock. Such transactions are routine in the pharmaceutical and biotechnology industries as part of executive compensation packages, reflecting the vesting of equity awards.

Related Party Transactions

• The conversion of restricted stock units into common stock by a company executive (Ira Duarte) is a standard related-party transaction as part of their compensation.

Stakeholder Impact

• Shareholders: The conversion of restricted stock units into common shares by a key executive may slightly increase the number of outstanding shares (if new shares are issued from a compensation plan), but primarily represents a change in the form of ownership for the executive.
• Employees: No direct impact on the broader employee base.

Next Steps

• Continued vesting of the remaining 38,743 restricted stock units in 16 equal quarterly installments.

Key Dates

Keywords

Heron Therapeutics, HRTX, Form 4, Insider Transaction, Restricted Stock Units, RSU Conversion, Ira Duarte, CFO, Executive Compensation